Tachyplesin

General Information


DRACP ID  DRACP04361

Peptide Name   Tachyplesin

Sequence  KWCFRVCYRGICYRRCRGK

Sequence Length  19

UniProt ID  P69135 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C107H169N37O22S4

Absent amino acids  ADEHLMNPQST

Common amino acids  R

Mass  277523

Pl  10.46

Basic residues  7

Acidic residues  0

Hydrophobic residues  4

Net charge  7

Boman Index  -6471

Hydrophobicity  -68.95

Aliphatic Index  35.79

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  8730

Absorbance 280nm  485

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35271828

Title  Tachyplesin and CyLoP-1 as efficient anti-mycobacterial peptides: A novel finding

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19029

DRACP is developed by Dr.Zheng's team.